Related Experiment Video
Updated: Feb 15, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI
Sascha Kaufmann1,2, Giorgio I Russo3,4, Fabian Bamberg1
1Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany.
Purpose:
To evaluate the detection rate among three different targeted biopsy approaches of robot-assisted MRI/TRUS fusion (RA-TB), mpMRI in-bore (MRGB), cognitive fusion guidance biopsy (COG-TB) for the detection of prostate cancer (PC) and clinically significant PC (csPC).
Methods:
Between 2014 and 2016, 156 patients with a lesion on mpMRI, performed in accordance with ESUR guidelines, due to cancer suspicion or on-going cancer suspicion after prior negative prostate biopsy, underwent targeted biopsy with RA-TB, MRGB or COG-TB. All lesions were rated according to PI-RADS v2. We compared detection rates between techniques. Models were constructed to predict the detection of overall PC and csPC and using a 1000 boot-strap sample.
Results:
In the all cohort, 73, 45 and 38 patients underwent RA-TB, MRGB or COG-TB, respectively. Overall PC was found in 39 (52.42%), 23 (51.11%) and 11 (28.95%) (p = 0.04) patients of RA-TB, MRGB and COG-TB arm, respectively. As concerning the detection of csPC, it was found in 26 (35.62%),18 (40.0%) and 9 (23.68%) patients of RA-TB, MRGB and COG-TB arm (p = 0.27). Model 1 showed that RA-TB [OR: 10.08 (95% CI 1.95-51.97); p < 0.01] and MRGB [OR: 12.88 (95% CI 2.36-70.25); p < 0.01] were associated with overall PC detection in TB, while only MRGB was associated with csPC at TB (model 2) [OR: 5.72; (95% CI 1.40-23.35); p < 0.01]. The c-index for model 1 and model 2 was 0.86 and 0.85, respectively. We did not report significant complications between groups.
Conclusion:
In-bore biopsy and MRI/TRUS fusion-guided biopsy showed greater accuracy in detecting PC compared to cognitive fusion as modeled in a newly established normogram.
Insights
Robot-assisted MRI/TRUS fusion (RA-TB) and in-bore MRI guided biopsy (MRGB) show higher prostate cancer (PC) detection rates than cognitive fusion biopsy (COG-TB). These targeted biopsy methods improve accuracy for detecting both PC and clinically significant PC (csPC).
Area of Science:
- Urology
- Oncology
- Medical Imaging
Background:
- Prostate cancer (PC) diagnosis relies on accurate detection of tumors.
- Targeted biopsy (TB) techniques aim to improve diagnostic accuracy over traditional methods.
- Comparing different TB approaches is crucial for optimizing patient outcomes.
Purpose of the Study:
- To compare the detection rates of prostate cancer (PC) and clinically significant PC (csPC) using three targeted biopsy (TB) methods.
- Evaluate robot-assisted MRI/TRUS fusion (RA-TB), in-bore MRI guided biopsy (MRGB), and cognitive fusion biopsy (COG-TB).
Main Methods:
- A cohort of 156 patients with suspicious MRI lesions underwent one of three TB techniques: RA-TB, MRGB, or COG-TB.
- Lesions were assessed using PI-RADS v2 criteria.
- Detection rates for PC and csPC were compared, and predictive models were developed.
Main Results:
- Overall PC detection rates were 52.42% for RA-TB, 51.11% for MRGB, and 28.95% for COG-TB (p=0.04).
- Clinically significant PC (csPC) detection rates were 35.62% for RA-TB, 40.0% for MRGB, and 23.68% for COG-TB (p=0.27).
- RA-TB and MRGB were significantly associated with overall PC detection, while MRGB was associated with csPC detection.
Conclusions:
- In-bore MRI guided biopsy (MRGB) and MRI/TRUS fusion-guided biopsy (RA-TB) demonstrate superior accuracy in detecting prostate cancer compared to cognitive fusion biopsy (COG-TB).
- These findings support the use of advanced fusion techniques for more precise PC diagnosis.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cognitive Dissonance
Negative Regulator Molecules
Positive, Negative, and Zero Work
Language and Cognition